BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of €9.63 billion as of February 11, 2026. Its market cap has decreased by -14.12% in one year.

Market Cap

9.63B

Enterprise Value

8.90B

Revenue

2.64B

Ranking

n/a

PE Ratio

21.71

Stock Price

€49.60

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 9.63B, an increase of 2,162.85%. That is a compound annual growth rate of 12.46%.

Market Cap History

Date	Market Cap	% Change
Feb 10, 2026	9.63B	-0.96%
Dec 31, 2025	9.72B	-19.63%
Dec 31, 2024	12.10B	-26.36%
Dec 29, 2023	16.43B	-8.70%
Dec 30, 2022	18.00B	26.18%
Dec 31, 2021	14.26B	9.60%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Moncler	13.13B
Edison	11.37B
Italgas	10.54B
Technoprobe	10.22B
Recordati Industria Chimica e Farmaceutica	9.66B
Buzzi	8.91B
Banca Popolare di Sondrio S.p.A	8.18B
A2A S.p.A.	7.94B

Market Cap Rankings